ArticlePDF Available

Spring is here, now what? Know the Difference Between a Cold, Flu, Coronavirus and Allergy.

Authors:
  • The RIPLRT Institute
  • Larkin University

Abstract

Q. What do we learn when we ask a Professor of Molecular Biology, Professor of Immunology, Professor of Ear Nose and Throat Surgery with over 30 years of allergy experience, Professor of Pharmaceutical Sciences, and a Professor of Medical Education? A. We learn the correct answers to some of the most current and confusing public health and medical questions relating to common allergies and infectious pathogens.
Citation: Nawaz Z, Pullen F, Rivera-Mariani FE, Rizvi SAA, Sanchez-Gonzalez MA, et al. (2020) Spring is Here, Now What? Know the difference
between a cold, u, coronavirus and allergy. Emerg Infect Dis Diag J: EIDDJ-100010
Emerg Infect Dis Diag J, an open access journal
ISSN 2652-4449
Emerging Infectious Diseases and
Diagnosis Journal
Short Review Article Nawaz Z, et al. Emerg Infect Dis Diag J: EIDDJ-100010
Spring is here, now what? Know the Difference Between a Cold,
Flu, Coronavirus and Allergy
Nawaz Z1*, Pullen F2, Rivera-Mariani FE3, Rizvi SAA4, Sanchez-Gonzalez MA5, Smollar M6 and Grogan T6
1Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL, USA
2Department of Otolaryngology, Miller School of Medicine, University of Miami, Miami, FL, USA
3College of Biomedical Sciences, Larkin University, Miami, FL, USA
4Department of Pharmaceutical Sciences, Hampton University School of Pharmacy, Hampton, VA, USA
5Division of Clinical & Translational Research, Larkin Health System, South Miami, FL, USA
6MedScience Research Group, Inc., West Palm Beach, FL, USA
Volume 02; Issue 01
1
*Corresponding author: Zafar Nawaz, Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of
Miami, Miami, FL, USA, Tel: (305) 243-1456; Email: znawaz@med.miami.edu
Citation: Nawaz Z, Pullen F, Rivera-Mariani FE, Rizvi SAA, Sanchez-Gonzalez MA, et al. (2020) Spring is Here, Now What? Know
the difference between a cold, u, coronavirus and allergy. Emerg Infect Dis Diag J: EIDDJ-100010
Received date:20 March, 2020; Accepted date:23 March, 2020; Published date: 30 March, 2020
Introduction
Q. What do we learn when we ask a Professor of Molecular Biology,
Professor of Immunology, Professor of Ear Nose and Throat
Surgery with over 30 years of allergy experience, Professor of
Pharmaceutical Sciences, and a Professor of Medical Education?
A.We learn the correct answers to some of the most current and
confusing public health and medical questions relating to common
allergies and infectious pathogens.
The Spring of 2020 is now upon us, but this season is
very alarming for many. Recently, because our population is
in a frenzy about the impact that the Novel coronavirus disease
2019 (COVID-19) may have, but it also coincides with the end
of the northern hemispheres winter. That has many people still
ill, suffering and passing on this year’s latest inuenza (the u)
orother winter infectious-related colds. In addition, a considerable
number of seasonal allergy sufferers are beginning to experience
their watery eyes, congestion and runny nose symptoms that they
dread year after year, due to their over-reacting immune system
and inammatory response, i.e., their allergies.
So, what is the difference between a cold, the u, the
coronavirus, and an allergy? The common cold, also known as
acute viral rhinopharyngitis and acute coryza, is a viral infection
of the upper respiratory system. On the other hand, the u results
from the infection by the inuenza virus, classied as types A and
B (most common), or C [1,2]. According to the Centers for Disease
Control and Prevention (CDC), inuenza in the United States this
year alone has caused an estimated 34 million illnesses, 350,000
hospitalizations and 20,000 deaths this season. So, viral diseases
are not new! The human population has been living with viral
infections for some time. Then, why the extraordinary reaction
to this newcoronavirus? The novel coronavirus 19, is a new strain
of coronaviruses (CoV) causing an upper respiratory infection
similar to common colds; however, previously other corona viruses
are implicated in respiratory complications including, Severe
Acute Respiratory Syndrome (SARS-CoV), and Middle East
Respiratory Syndrome (MERS-CoV). According to Dr. Anthony
Fauci, director of the National Institutes of Allergy and Infectious
Diseases (NIAID), “guarantee as we get into March and April u
cases are going to go down, you can predict pretty accurately what
the range of the mortality and hospitalizations will be. The issue
now with COVID-19 is there’s a lot of unknowns”. According to
the CDC report, as of the time and date of this submission, March
15, 2020 the total COVID-19 cases in the United States were 2952,
and the total deaths 57[3]. According to the CDC, the symptoms
of the coronavirus include a fever of 101.4 or higher, cough, and
shortness of breath. It is associated with an incubation exposure
of 2 to 14 days. Usually, there’s no evidence of runny nose or sore
throat (Table 1). The inuenza virus usually begins with a stuffy
nose followed by a sore throat and then cough. These symptoms
2
Citation: Nawaz Z, Pullen F, Rivera-Mariani FE, Rizvi SAA, Sanchez-Gonzalez MA, et al. (2020) Spring is Here, Now What? Know the difference
between a cold, u, coronavirus and allergy. Emerg Infect Dis Diag J: EIDDJ-100010
Volume 02; Issue 01
Emerg Infect Dis Diag J, an open access journal
ISSN 2652-4449
3
may last 2 to 3 weeks, but in some cases, it could be even longer. An allergic reaction such as allergic rhinitis, on the other hand, usually
begins with a stuffy nose, runny nose, postnasal drip, itchiness of the nose or throat, followed by sneezing. It is rarely associated with a
sore throat. It will last for longer than 2 to 3 weeks and may last for several months. It may also be associated with a cough due to the
copious postnasal drip of mucus.
Symptoms
Disease Fever Cough Shortness of Breath Runny Nose Itchy Sore
Throat
Incubation
Time
Flu Yes Yes No Yes No Yes 2-4 Days
COVID
19
Yes. 101.4 and
above Yes Yes No No No 2-14 Days
Allergy No Yes No Yes Yes No Months
Table 1:These symptoms may last 2 to 3 weeks, but in some cases, it could be even longer.
Allergies are when your immune system reacts to a foreign
substance called an allergen, and it might be the newly released
pollen or something you inhale or inject or touch or even food
items. The reaction causes coughing, sneezing, itchy eyes, runny
nose and a scratchy throat. Seasonal allergies begin primarily in the
spring, and since we are in the early stages of spring, we thought
it would be interesting to give a little background on allergies. For
example, spring allergies are caused by the release of pollen into
the air primarily from trees that had begun to bloom. The most
common of these include Birch, Bayberry, Elms, Oak, Maple,
Pine, especially Australian, and even some Palm trees. When you
go out to your car in the morning, you may see yellow dust all over
it: that is tree pollen. Coincidentally, just a few weeks ago, in early
March 2020, the Larkin Community Hospital Institutional Review
Board (IRB) in Miami approved a rst of its time novel study titled
Patient Education: Do you know your Allergy IQ? This timely
study aims to evaluate responder’s allergy knowledge and beliefs
relating to common allergen triggers and environmental control
strategies, comparing doctors and other health professionals to
laypeople to nd out who knows more about their allergies.
Do you know your Allergy IQ? Test yourself with these sample
questions:
Which symptom helps to tell the difference between an allergy, a
cold, or a virus?
a) Stuffy nose
b) Cough
c) Headache
d) Itchiness
Over half of those that took the survey got the answer wrong.
A chemical called histamine is the usual culprit for the
sensation of itchy nose, eyes, or skin found in allergy. Colds, Flu’s,
and viruses don’t tend to make you feel itchy.
Which is the main allergen (a substance that triggers allergy)
that hits many spring allergy sufferers?
a) Tree
b) Ragweed
c) Mold
d) Dust mites
If you suffer from seasonal allergies caused by tree pollen,
you want to know this. Our data showed only 8% of quiz respond-
ers got this answer correct. In many areas of the United States,
spring allergies begin in February and last until the early summer.
Tree pollination begins early in the year followed by grass pollina-
tion later in the spring and summer and ragweed in the late sum-
mer and fall. In tropical climates, however, grass may pollinate
throughout a good portion of the year. Mild winter temperatures
can cause plants to pollinate early.
What is the best way to prevent seasonal allergy symptoms on a
high-pollen day?
a) Create a ‘pet free’ bedroom
b) Brush/wipe your pet before entering the home
c) Pretreat with your allergy medications before exposure
d) All of the above
Our current sample data found that 84% answered this question
incorrectly.
Speak with your doctor or pharmacist and start taking
allergy medicine before the pollen season or high pollen count
days to help you more than waiting to experience and react to your
allergysymptoms
Here are the facts
Allergy is currently the 6th leading chronic disease in the
US [4].
3
Citation: Nawaz Z, Pullen F, Rivera-Mariani FE, Rizvi SAA, Sanchez-Gonzalez MA, et al. (2020) Spring is Here, Now What? Know the difference
between a cold, u, coronavirus and allergy. Emerg Infect Dis Diag J: EIDDJ-100010
Volume 02; Issue 01
Emerg Infect Dis Diag J, an open access journal
ISSN 2652-4449
Allergy affects over 50M Americans [4].
Allergies and Asthma cost the economy $Billions each
year [4].
There is a published shortage of Board-certied Allergy
specialists to treat the number of allergy sufferers [5].
There are identied gaps in primary care provider (PCP)
and non-allergy board-certied specialist training/
knowledge relating to evidence-based allergic disease
management [6].
Allergen triggers and understanding of environmental
control strategies for allergic diseases can be confusing
[7].
Many allergy sufferers self-medicate using OTC
medications without consulting their medical
professional’s advice [8].
Evidence-based prevention strategies currently exist for
better controlling and/or managing allergies [7].
Based on these facts, when you know you have an allergy
and not a viral infection, what can you do? The immune response
to an allergen (in most cases, otherwise benign substances such as
pollen, animal dander, etc.) starts with sensitization (i.e. immune
system “getting confused”) followed by the development of a
specic immune response (production of an allergen-specic
antibody) towards the usually benign substance. Allergic rhinitis
(itchy, watery eyes, and sneezing) is also antibody-mediated, such as
Immunoglobulin E, inammatory response that affects up to 40% of
the population worldwide [9]. Avoiding exposure to allergen is the
rst step. It should be part of an overall treatment strategy, followed
by the use of either over the counter or prescription medications
to address the symptoms. The most common oral medications,
Zyrtec (cetirizine), Allegra (fexofenadine), Xyzal (levocetirizine),
Claritin (loratadin), Benadryl (diphenhydramine), Dimetapp
(Brompheniramine), Chlor-Trimeton (chlorpheniramine), and
Tavist (clemastine) are found over the counter. These medications
help to alleviate the symptoms but do not treat the cause of your
allergy specic allergen reaction. As of now, only allergen-
specic immunotherapy is known to cure the disease[10]. When
medication treatment is no longer successful or avoidance is not
possible, such as being allergic to family pets such as cats or
dogs, immunotherapy is recommended. Today, immunotherapy
is available in both the traditional injection method and, in some
instances, with oral drops or tablets: this is the only mechanism
that actually overcomes the allergy permanently.
Allergen Immunotherapy (Desensitization)
Desensitization is increasingly being prescribed
therapeutically by many physicians to reduce allergen-specic
sensitivity. Low doses of offending allergens are slowly introduced
to the immune system by allergy shots or oral tablets or drops
similar to other types of vaccines. Patients who tolerate the
allergen immunotherapy have these doses progressively increased
based on the patient’s tolerance. Doses are delivered weekly in
the case of injections or daily with oral treatment. These regimens
are becoming more standardized and generally agreed upon by
national and international allergy and immunology societies. The
end result is the same. The body has become immunized to the
allergens that have caused you such discomfort.
How does it work?
When exposed to the natural allergen (pollen), the body
releases chemicals that cause allergic reactions seen in allergic
rhinitis. These chemicals are what make you often feel very
itchy in the nose, eyes, or skin. That is why anti-histamines are
recommended for allergic symptoms.The changes to the immune
system as a result of immunotherapy are divided into immediate
and late effects. Many researchers agree that around 6-8 weeks
after commencing allergen immunotherapy treatment, a kind of
intelligent white blood cell promotes the production of specic
proteins that reduce pro-inammatory chemicals. The production
of these proteins, as a result, has a positive effect on the over-
reactive immune system. The benet from the body’s production
of this protein gradually increases over 2-3 years and, in some
sufferers, alleviates the allergy permanently.
The future
Medical scientists continue to seek the exact scientic
mechanisms to explain how allergen immunotherapy works.
Nevertheless, suffering patients who are sensitive to environmental
allergens such as tree pollen during springtime continue to show
impressive results with available medications and allergen
immunotherapy. The future will likely be treatment with
nanoparticles of the offending antigen and will also include many
food allergies.
Conclusion
COVID-19 indeed represents an important public health
concern affecting the nation at this point. However, it is essential
to point out that COVID-19 has coincided with seasonal diseases
such as the u and the upcoming spring with its increases in
allergic cases. Recognizing the signs and symptoms of each of
these conditions is an important step in minimizing the impact
of both infectious and non-infectious disorders such as allergic
disease in the general public.
References
Paules C and Subbarao K (2017) Inuenza. Lancet 390: 697-7081. .
Worrall G (2011) Common cold. Can Fam Physician 57: 1289-12902. .
https://www.cdc.gov/coronavirus/2019-nCoV/index.html. 3.
https://acaai.org/news/facts-statistics/allergies. 4.
American College of Allergy, Asthma and Immunology. Graduate 5.
Medical Education and Workforce Issues in Allergy and Immunology.
2008.
Smith HE, Wade J, Frew AJ (2016) What proportion of adult allergy 6.
referrals to secondary care could be dealt with in primary care by a GP
with special interest?.ClinTransl Allergy 6: 3.
4
Citation: Nawaz Z, Pullen F, Rivera-Mariani FE, Rizvi SAA, Sanchez-Gonzalez MA, et al. (2020) Spring is Here, Now What? Know the difference
between a cold, u, coronavirus and allergy. Emerg Infect Dis Diag J: EIDDJ-100010
Volume 02; Issue 01
Emerg Infect Dis Diag J, an open access journal
ISSN 2652-4449
https://acaai.org/allergies/allergy-treatment/environmental-trigger-7.
avoidance.
Tan R, Cvetkovski B, Kritikos V, Price D, Yan K, et al. (2017) Identify-8.
ing the hidden burden of allergic rhinitis (AR) in community pharmacy:
a global phenomenon. Asthma Res Pract 3: 8.
May JR and Dolen WK (2017) Management of Allergic Rhinitis: A Re-9.
view for the Community Pharmacist. ClinTher 39: 2410-2419.
Moote W, Kim H, Ellis AK (2018) Allergen-specic immunotherapy. Al-10.
lergy Asthma ClinImmunol 14: 53.
... From a clinical perspective, patients are often unaware of their allergy triggers, allergic environments, and types of medications that best contribute to their overall symptom control. 8 Clinicians are required to uncover specifically which environmental conditions, triggers, and medications relate to an individual patient's symptom severity-not a simple "one size fits all" scenario. Primary care visits are becoming shorter, and clinicians have to cover other, more-urgent patient concerns first, lowering the priority of asking about allergy symptoms. ...
Article
Full-text available
Allergic conditions are the most common life-altering, and sometimes life-threatening, disorders affecting millions of individuals worldwide. Oftentimes, people with allergies and their health care providers neglect to discuss the symptoms of allergy, and thus, proper diagnoses are not made and treatment is not initiated. The aim of this manuscript is to describe the development of a tool for improved management and treatment of allergies in the primary care setting.
Article
Full-text available
Background Patients with allergic rhinitis often trivialise their condition, self-manage inappropriately, and would benefit from health care intervention. The primary point of health care contact for these self-managing allergic rhinitis patients is the community pharmacy. With the majority of allergic rhinitis treatments being available for purchase over the counter, without health care professional contact, we know little about how the patients self-manage. This study aims to identify the burden of allergic rhinitis in the community pharmacy and to identify key opportunity for intervention. Methods Pharmacy customers, who purchased nasal treatment in a community pharmacy, were approached with a research-administered questionnaire that collected data on medical history, symptoms and products purchased for the treatment of nasal symptoms. ResultsOf the 296 participants, 69.9% self-managed with over-the-counter medications; with 68% experiencing allergic rhinitis symptoms and only 44.3% of this subgroup had a doctor’s diagnosis. Nasal congestion (73.6%) was most commonly experienced and oral antihistamines were most commonly purchased (44.3%), indicating a pattern of suboptimal management. A third of participants (36.5%) experienced moderate-severe symptoms, persistently, which impacted on their daily living. Medication selection was mainly based on pharmacy customers’ perceptions of medication effectiveness (47.6%). ConclusionA majority of participants that self-selected over-the-counter medications have symptoms consistent with allergic rhinitis, with almost half not having received a diagnosis. Medication purchasing patterns suggest that sub-optimal therapeutic decisions made by participants, even when they are experiencing significant symptoms. This study uncovers the hidden burden of allergic rhinitis in the community pharmacy and a missed opportunity to intervene and refer if necessary. Patients need to be guided through appropriate treatment as this study showed that many should be referred to a medical practitioner.
Article
Full-text available
Purpose: Allergic rhinitis is a highly prevalent disease affecting the quality of life of millions of North Americans. The management of allergic rhinitis includes allergen avoidance, pharmacotherapy, and immunotherapy. Current pharmacologic options include oral and intranasal antihistamines, intranasal corticosteroids, oral and intranasal decongestants, oral and intranasal anticholinergics, and leukotriene receptor antagonists. Second-generation oral antihistamines and intranasal corticosteroids are the mainstays of treatment, with practice guidelines recommending intranasal corticosteroids as first-line treatment for moderate to severe allergic rhinitis. Methods: Clinical trials studying a widely used intranasal corticosteroid, fluticasone propionate, in comparison with second-generation oral antihistamines, cetirizine, loratadine, or montelukast, were selected to support the comparative review of the efficacy and tolerability of these 2 classes of medications. Studies evaluating the combination of fluticasone propionate with an oral antihistamine were also included to review the efficacy and tolerability of combination therapy to treat allergic rhinitis. Findings: Studies comparing fluticasone propionate with cetirizine had mixed findings; fluticasone propionate was found to have equal or greater efficacy in reducing nasal symptom scores. Combination therapy of fluticasone propionate and the oral antihistamine, loratadine, was found to have efficacy comparable with that of intranasal corticosteroid alone. Implications: Many of these medications are available over the counter in the pharmacy, and the community pharmacist plays an important role as part of the patient's health care team in managing this disease. Pharmacotherapy is patient-specific, based on type, duration, and severity of symptoms, comorbidities, prior treatment, and patient preference. This article aims to provide an overview of the pathophysiology, available treatment options, guideline recommendations, and role of the pharmacist for this disease.
Article
Full-text available
Background: The concept of a General Practitioner with Special Interest (GPwSI) was first proposed in the 2000 National Health Service Plan, as a way of providing specialised treatment closer to the patient's home and reducing hospital waiting times. Given the patchy and inadequate provision of allergy services in the UK the introduction of GPwSIs might reduce the pressure on existing specialist services. Objectives: This study assessed what proportion of referrals to a specialist allergy clinic could be managed in a GPwSI allergy service with a predefined range of facilities and expertise (accurate diagnosis and management of allergy; skin prick testing; provision of advice on allergen avoidance; ability to assess suitability for desensitisation). Methods: 100 consecutive GP referrals to a hospital allergy clinic were reviewed to determine whether patients could be seen in a community-based clinic led by a general practitioner with special interest (GPwSI) allergy. The documentation relating to each referral was independently assessed by three allergy specialists. The referrals were judged initially on the referral letter alone and then re-assessed with the benefit of information summarised in the clinic letter, to determine whether appropriate triage decisions could be made prospectively. The proportion of referrals suitable for a GPwSI was calculated and their referral characteristics identified. Results: 29 % referrals were judged unanimously appropriate for management by a GPwSI and an additional 30 % by 2 of the 3 reviewers. 18 % referrals were unsuitable for a GPwSI service because of the complexity of the presenting problem, patient co-morbidity or the need for specialist knowledge or facilities. Conclusions and clinical relevance: At least a quarter, and possibly half, of allergy referrals to our hospital-based service could be dealt with in a GPwSI clinic, thereby diversifying the patient pathway, allowing specialist services to focus on more complex cases and reducing the waiting time for first appointments.
Article
Influenza is an acute respiratory illness, caused by influenza A, B, and C viruses, that occurs in local outbreaks or seasonal epidemics. Clinical illness follows a short incubation period and presentation ranges from asymptomatic to fulminant, depending on the characteristics of both the virus and the individual host. Influenza A viruses can also cause sporadic infections or spread worldwide in a pandemic when novel strains emerge in the human population from an animal host. New approaches to influenza prevention and treatment for management of both seasonal influenza epidemics and pandemics are desirable. In this Seminar, we discuss the clinical presentation, transmission, diagnosis, management, and prevention of seasonal influenza infection. We also review the animal–human interface of influenza, with a focus on current pandemic threats.
Allergen-specific immunotherapy. Al-10. lergy
  • W Moote
  • H Kim
  • A K Ellis
Moote W, Kim H, Ellis AK (2018) Allergen-specific immunotherapy. Al-10. lergy Asthma ClinImmunol 14: 53.